[go: up one dir, main page]

GB9607955D0 - Hydrophobic carbomer salt compositions - Google Patents

Hydrophobic carbomer salt compositions

Info

Publication number
GB9607955D0
GB9607955D0 GBGB9607955.3A GB9607955A GB9607955D0 GB 9607955 D0 GB9607955 D0 GB 9607955D0 GB 9607955 A GB9607955 A GB 9607955A GB 9607955 D0 GB9607955 D0 GB 9607955D0
Authority
GB
United Kingdom
Prior art keywords
hydrophobic
salt compositions
carbomer
carbomer salt
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9607955.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tillotts Pharma AG
Original Assignee
Tillotts Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tillotts Pharma AG filed Critical Tillotts Pharma AG
Priority to GBGB9607955.3A priority Critical patent/GB9607955D0/en
Publication of GB9607955D0 publication Critical patent/GB9607955D0/en
Priority to PCT/EP1997/001847 priority patent/WO1997038726A2/en
Priority to CA002251849A priority patent/CA2251849A1/en
Priority to AU26965/97A priority patent/AU2696597A/en
Priority to EP97920670A priority patent/EP0914160A2/en
Priority to JP53674097A priority patent/JP2001509781A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
GBGB9607955.3A 1996-04-17 1996-04-17 Hydrophobic carbomer salt compositions Pending GB9607955D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9607955.3A GB9607955D0 (en) 1996-04-17 1996-04-17 Hydrophobic carbomer salt compositions
PCT/EP1997/001847 WO1997038726A2 (en) 1996-04-17 1997-04-14 Hydrophobic carbomer complex compositions
CA002251849A CA2251849A1 (en) 1996-04-17 1997-04-14 Hydrophobic carbomer complex compositions
AU26965/97A AU2696597A (en) 1996-04-17 1997-04-14 Hydrophobic carbomer complex compositions
EP97920670A EP0914160A2 (en) 1996-04-17 1997-04-14 Hydrophobic carbomer complex compositions
JP53674097A JP2001509781A (en) 1996-04-17 1997-04-14 Hydrophobic carbomer complex composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9607955.3A GB9607955D0 (en) 1996-04-17 1996-04-17 Hydrophobic carbomer salt compositions

Publications (1)

Publication Number Publication Date
GB9607955D0 true GB9607955D0 (en) 1996-06-19

Family

ID=10792216

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9607955.3A Pending GB9607955D0 (en) 1996-04-17 1996-04-17 Hydrophobic carbomer salt compositions

Country Status (6)

Country Link
EP (1) EP0914160A2 (en)
JP (1) JP2001509781A (en)
AU (1) AU2696597A (en)
CA (1) CA2251849A1 (en)
GB (1) GB9607955D0 (en)
WO (1) WO1997038726A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5889028A (en) * 1996-02-09 1999-03-30 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
EP1307232B1 (en) 2000-08-03 2007-03-07 Antares Pharma IPL AG Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
AU2003298010A1 (en) * 2002-12-19 2004-07-29 Pharmacia Corporation Non-hygroscopic formulation comprising a hydroscopic drug
BRPI0414551B8 (en) 2003-10-10 2021-05-25 Antares Pharma Ipl Ag transdermal or transmucosal pharmaceutical formulation and method of delaying or inhibiting crystallization of an active agent
CN116657439B (en) * 2023-06-29 2024-09-17 浙江科技学院 Preparation method of high-uniformity carbon paper base paper of pH response type dispersion system
WO2025236078A1 (en) * 2024-05-09 2025-11-20 Tjp Labs Inc. Stabilized nicotine particles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246037B2 (en) * 1972-09-20 1975-02-27 Taeschner & Co, 8831 Kipfenberg Orally applicable drug with delayed absorption in suspension form
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
US5843482A (en) * 1990-07-20 1998-12-01 Tillotts Pharma Ag Products and processes for the treatment of the alimentary canal
TW209174B (en) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
IT1251153B (en) * 1991-08-06 1995-05-04 Vectorpharma Int SOLID PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION HAVING PROHIBITED GASTRIC RESIDENCE
IT1256134B (en) * 1992-09-09 1995-11-29 Luigi Boltri LYPHOPHILIC SALTS CONTAINING ACTUABLE NEUTRON ISOTOPES AND COMPOSITIONS CONTAINING THEM
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system

Also Published As

Publication number Publication date
EP0914160A2 (en) 1999-05-12
AU2696597A (en) 1997-11-07
CA2251849A1 (en) 1997-10-23
WO1997038726A3 (en) 1997-12-31
WO1997038726A2 (en) 1997-10-23
JP2001509781A (en) 2001-07-24

Similar Documents

Publication Publication Date Title
AU2930597A (en) Salt compositions
EG20993A (en) Cleasing compositions
ZA965380B (en) Herbicidal compositions
EG20989A (en) Cleasing compositions
GB9613043D0 (en) Improved compositions
GB9500577D0 (en) Compositions
ZA961522B (en) Fungicidal composition
GB9504996D0 (en) Compositions
ZA9710961B (en) Herbicidal compositions
ZA969798B (en) Herbicidal composition
IL124995A0 (en) Herbicidal compositions
PL334006A1 (en) Lyophilisable pharmaceutic compositions
PL329919A1 (en) Diclophenac-based pharmaceutic compositions
ZA96400B (en) Herbicidal composition
PL337181A1 (en) Novel salt
GB9607955D0 (en) Hydrophobic carbomer salt compositions
AP9801229A0 (en) Solid compositions
ZA969639B (en) Herbicidal compositions
ZA988299B (en) Agrochemical compositions
ZA9610348B (en) Herbicidal compositions
GB9713732D0 (en) Substituted triazinic compounds
GB9809350D0 (en) Novel salt
IL116958A0 (en) Fungicidal compositions
PL318520A1 (en) Herbicidal composition
IL117704A0 (en) Herbicidal compositions